Aidan Cross
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 detection and testing 3
-
- COVID-19 epidemiological studies 1
- Journals
- Scientific Reports (2 papers)BMC Infectious Diseases (1 paper)The Lancet Infectious Diseases (1 paper)Nature (1 paper)Journal of Hospital Infection (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Aidan Cross
8 papers receiving 928 citations
Aidan Cross's Hit Papers
Peers
Comparison fields: 5 of 74
- Infectious Diseases 718
- Modeling and Simulation 115
- Animal Science and Zoology 77
- Neurology 59
- Immunology 79
Countries citing papers authored by Aidan Cross
This map shows the geographic impact of Aidan Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aidan Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aidan Cross more than expected).
Fields of papers citing papers by Aidan Cross
This network shows the impact of papers produced by Aidan Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aidan Cross. The network helps show where Aidan Cross may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Hit paper breakdown → | 2022 | 457 |
| 2 | Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study Hit paper breakdown → | 2021 | 290 |
| 3 | 2021 | 67 | |
| 4 | 2021 | 66 | |
| 5 | 2022 | 41 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 8 | |
| 8 | 2023 | 1 |
About Aidan Cross
Aidan Cross is a scholar working on Infectious Diseases, Modeling and Simulation, Animal Science and Zoology, Immunology and Plant Science, having authored 8 papers that have together received 944 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 detection and testing (3 papers), Animal Virus Infections Studies (1 paper), COVID-19 epidemiological studies (1 paper), Plant Virus Research Studies (1 paper) and Immune responses and vaccinations (1 paper). The work is most often cited by research in Infectious Diseases (718 citations), Modeling and Simulation (115 citations), Animal Science and Zoology (77 citations), Neurology (59 citations) and Immunology (79 citations). Aidan Cross has collaborated with scholars based in United Kingdom. Their work appears in journals such as Scientific Reports, BMC Infectious Diseases, The Lancet Infectious Diseases, Nature and Journal of Hospital Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.